Patents by Inventor Elizabeth Helkkila

Elizabeth Helkkila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
    Publication number: 20060178330
    Abstract: The present invention relates to apoptosis specific eucaryotic initiation factor 5A (eIF-5A), referred to as apoptosis factor 5A1 or simply factor 5A1, apoptosis factor 5A1 nucleic acids and polypeptides and methods for inhibiting or suppressing apoptosis in cells using antisense nucleotides or siRNAs to inhibit expression of factor 5A1. The invention also relates to suppressing or inhibiting expression of pro-inflammatory cytokines by inhibiting expression of apoptosis factor 5A.
    Type: Application
    Filed: November 28, 2005
    Publication date: August 10, 2006
    Applicant: Senesco Technologies, Inc.
    Inventors: John Thompson, Bruce Galton, Catherine Taylor, Adrienne Boone, Elizabeth Helkkila, Dominic Cliche, Shelley Culp-Stewart, John Flanagan, Michelle Senchyna